Oramed Pharmaceuticals In... (ORMP)
NASDAQ: ORMP
· Real-Time Price · USD
2.06
-0.02 (-0.96%)
At close: Aug 19, 2025, 1:10 PM
Oramed Pharmaceuticals Revenue
Oramed Pharmaceuticals reported an annual revenue of $1.34M, reflecting a -50.43% growth. For the quarter ending September 30, 2024, Oramed Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
1.34M
Revenue Growth
-50.43%
Price / Sales Ratio
69.5
Revenue / Employee
103.08K
Employees
13
Market Cap
84.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 1.34M | -50.43% |
| Dec 31, 2022 | 2.7M | n/a |
| Aug 31, 2021 | 2.7M | -0.26% |
| Aug 31, 2020 | 2.71M | +0.26% |
| Aug 31, 2019 | 2.7M | +10.37% |
| Aug 31, 2018 | 2.45M | -0.29% |
| Aug 31, 2017 | 2.46M | +283.15% |
| Aug 31, 2016 | 641K | +Infinity% |
| Aug 31, 2015 | 0 | n/a |
| Aug 31, 2014 | 0 | n/a |
| Aug 31, 2013 | 0 | -100.00% |
| Aug 31, 2012 | 184.25K | -6.67% |
| Aug 31, 2011 | 197.41K | +Infinity% |
| Aug 31, 2010 | 0 | n/a |
| Aug 31, 2009 | 0 | n/a |
| Aug 31, 2008 | 0 | n/a |
| Aug 31, 2007 | 0 | n/a |
| Aug 31, 2006 | 0 | n/a |
| Aug 31, 2005 | 0 | n/a |
| Aug 31, 2004 | 0 | n/a |
| Aug 31, 2003 | 0 | n/a |